Literature DB >> 6794992

Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis.

T Sicilia, E Estévez, A Rodríguez.   

Abstract

A comparative study was made of the penetration of fosfomycin, penicillin G, ampicillin and chloramphenicol into the cerebrospinal fluid of patients with meningitis treated with combinations of fosfomycin and one of the other three antibiotics. Minimal inhibitory concentrations and in vitro interaction of these antibiotics against Streptococcus pneumoniae and Neisseria meningitidis strains were determined. 90-96.5% of these strains were sensitive to penicillin G, 95-96.5% to ampicillin, 85-100% to chloramphenicol and 90-100% to fosfomycin. Fosfomycin shows a more marked synergism with penicillin G or ampicillin than with chloramphenicol against both bacterial species. The percentages of penetration into the cerebrospinal fluid were: chloramphenicol, 32%; fosfomycin, 25.7%; ampicillin, 15.9%, and penicillin G, 7.9%. The clinical results show that the combination of fosfomycin + penicillin G or fosfomycin + ampicillin can be an alternative in the treatment of meningitis produced by moderately susceptible strains of S. pneumoniae and N. meningitidis to penicillin G and ampicillin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794992     DOI: 10.1159/000238009

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  9 in total

Review 1.  Plasmid-encoded fosfomycin resistance.

Authors:  J E Suárez; M C Mendoza
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; N Peyrard; A Pechinot; M Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges.

Authors:  E Kühnen; G Pfeifer; C Frenkel
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

4.  Streptococcus suis meningitis requires prolonged treatment with penicillin.

Authors:  J Woo; E K Li
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

5.  In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; H Beloeil; A Pechinot; F Duigou; J C Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

6.  In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus.

Authors:  S Alvarez; M Jones; S L Berk
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

7.  Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections.

Authors:  H Portier; A Kazmierczak; F Lucht; J C Tremeaux; P Chavanet; J M Duez
Journal:  Infection       Date:  1985       Impact factor: 3.553

8.  Bactericidal activity of cefotaxime and fosfomycin in cerebrospinal fluid during the treatment of rabbit meningitis experimentally induced by methicillin-resistant Staphylococcus aureus.

Authors:  A Kazmierczak; A Pechinot; J C Tremeaux; J M Duez; E Kohli; H Portier
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 9.  Fosfomycin: Uses and potentialities in veterinary medicine.

Authors:  D S Pérez; M O Tapia; A L Soraci
Journal:  Open Vet J       Date:  2014-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.